Explore PMI Science, where innovation meets harm reduction. Learn about our scientists, smoke-free research, and commitment to transparency in research.
PMI offers smoke-free alternatives with the potential to reduce the risk of harm for adult smokers who do not quit. Learn about harm reduction, the role of nicotine, and the regulation of smoke-free products.
Discover PMI's rigorous scientific approach to smoke-free products and product assessment. Dive into our research results, peer-reviewed publications, independent research, and expert reports.
PMI believes that offering a range of smoke-free alternatives is essential to ensure individual smokers are able to find a smoke-free product that they can fully switch to.
Explore the latest insights and stay informed about upcoming events and conference presentations from PMI scientists.
Ask a question or send us feedback. We're happy to answer.
Kogel, U.; Wong, E. T.; Titz, B.; Boue, S.; Elamin, A.; Vuillaume, G.; Leroy, P.; Ivanov, N. V.; Rodrigo, G.; Veljkovic, E.; Hoeng, J.; Vanscheeuwijck, P.; Peitsch, M. C.
Smoking causes serious diseases such as lung cancer, cardiovascular disease and chronic obstructive diseases. Undoubtedly, the best way for smokers to prevent the adverse health effects of tobacco is to quit smoking. Over the last years, tobacco harm reduction has also emerged as a policy that can complement traditional tobacco control intervention such as prevention and cessation.Here we show results of a 90-day rat inhalation study that was conducted in accordance with Organization for Economic Co-operation and Development (OECD) test guidance 413 to characterize potential adverse effects, caused by subchronic exposure to the tobacco heating system (THS) 2.2 aerosol, a heat-not-burn tobacco product, and to compare with those induced by the smoke generated from the reference cigarette 3R4F. In addition, a systems toxicology approach with additional animals was included to further characterize the exposure effects on the transcriptome and proteome of the lung, also referred to a OECD (+).THS 2.2 consists of three distinct components: (i) an electrically heated tobacco product (EHTP), with unique processed tobacco made from tobacco powder, (ii) a holder into which the EHTP is inserted and which heats the tobacco material by means of an electronically controlled heater, and (iii) a charger that is used to recharge the holder after each use. The holder heats the EHTP at a temperature not exceeding 350°C.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.